Safety and Efficacy of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors vs. Erythropoietin-Stimulating Agents in Treating Anemia in Renal Patients (With or Without Dialysis): A Meta-Analysis and Systematic Review-Reference-Cited by-同舟云学术

Safety and Efficacy of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors vs. Erythropoietin-Stimulating Agents in Treating Anemia in Renal Patients (With or Without Dialysis): A Meta-Analysis and Systematic Review

Published:2023-10-21 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Damarlapally Nanush,Thimmappa Vijaylaxmi,Irfan Hamza,Sikandari Muhammad,Madhu Krupa,Desai Aayushi,Pavani Peddi,Zakir Syeda,Gupta Manvi,Khosa Maha Mushtaq,Kotak Sohny,Varrassi Giustino,Khatri Mahima,Kumar Satesh

Publisher

Springer Science and Business Media LLC

Subject

Aerospace Engineering

Reference51 articles.

1. Anaemia in kidney disease: harnessing hypoxia responses for therapy;Koury MJ;Nat Rev Nephrol,2015

2. Hypoxia-inducible factor activators in renal anemia: current clinical experience;Sanghani NS;Adv Chronic Kidney Dis,2019

3. Evolving strategies in the treatment of anemia in chronic kidney disease: the HIF-prolyl hydroxylase inhibitors;Locatelli F;Drugs,2022

4. Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease;Haase VH;Kidney Int Suppl (2011),2021

5. Evolution of treatment for anemia in chronic kidney disease;Vaught K;J Ren Nutr,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal anemia: from relative insufficiency of EPO to imbalance of erythropoiesis and eryptosis;International Urology and Nephrology;2024-07-09

2. Evaluating the safety and efficacy of vadadustat for the treatment of anemia associated with chronic kidney disease;Expert Opinion on Pharmacotherapy;2024-06-12

3. Growing concerns about using hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of renal anemia;Clinical Kidney Journal;2024-02-28